EDITORIAL
Published on 25 Sep 2020
Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
doi 10.3389/fphar.2020.591188
- 1,826 views
- 1 citation
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies, Volume I
Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies, Volume I
44k
Total downloads
149k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 07 Apr 2020
Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
doi 10.3389/fphar.2020.00441
- 9,868 views
- 58 citations
ORIGINAL RESEARCH
Published on 13 Feb 2020
miR-20a-5p/TGFBR2 Axis Affects Pro-inflammatory Macrophages and Aggravates Liver Fibrosis
doi 10.3389/fonc.2020.00107
- 4,577 views
- 45 citations
ORIGINAL RESEARCH
Published on 04 Feb 2020
High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas
doi 10.3389/fonc.2020.00078
- 4,786 views
- 18 citations
CORRECTION
Published on 31 Jan 2020
Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition
doi 10.3389/fphar.2019.01615
- 1,388 views
- 2 citations
SYSTEMATIC REVIEW
Published on 30 Jan 2020
Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials
doi 10.3389/fphar.2019.01671
- 4,266 views
- 54 citations
CASE REPORT
Published on 18 Dec 2019
Severe Immune-Related Pneumonitis With PD-1 Inhibitor After Progression on Previous PD-L1 Inhibitor in Small Cell Lung Cancer: A Case Report and Review of the Literature
doi 10.3389/fonc.2019.01437
- 6,076 views
- 15 citations
SYSTEMATIC REVIEW
Published on 06 Dec 2019
Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies
doi 10.3389/fphar.2019.01453
- 2,920 views
- 28 citations
REVIEW
Published on 15 Oct 2019
The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
doi 10.3389/fonc.2019.01073
- 6,858 views
- 33 citations
SYSTEMATIC REVIEW
Published on 30 Aug 2019
Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis
doi 10.3389/fphar.2019.00962
- 2,796 views
- 34 citations
ORIGINAL RESEARCH
Published on 14 May 2019
Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition
doi 10.3389/fphar.2019.00511
- 6,410 views
- 66 citations
SYSTEMATIC REVIEW
Published on 28 Feb 2019
The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
doi 10.3389/fphar.2019.00139
- 7,306 views
- 86 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 149kTopic views
- 101kArticle views
- 44kArticle downloads